Cited by 447Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesTransplantation: Methods and Outcomes

Time course of bleomycin‐induced lung fibrosis

Open access
Izbicki, G., Segel, M.J., Christensen, T.G., Conner, M.W., Breuer, R.·2002·International Journal of Experimental Pathology

Abstract

Summary.: Intratracheal instillation (IT) of bleomycin is a widely used experimental model for lung fibrosis. In this study we describe the time‐course of bleomycin‐induced lung fibrosis in mice using computer‐assisted morphometry. C57Bl/6J mice were treated with a single IT dose of bleomycin or control saline. Animals were killed 3, 6, 14 and 21 days post‐IT. Lung injury was evaluated by analysis of bronchoalveolar lavage (BAL) fluid, hydroxyproline concentration in the lung, routine light microscopic examination resulting in a semiquantitative morphological index (SMI) of lung injury, and quantitative morphological measurements (fibrosis fraction and alveolar wall area fraction) aided by optimas image analysis software. Changes in BAL fluid attributed to bleomycin treatment include increased total cell count (days 14 and 21), and increased percentage of neutrophils (days 3 and 6) followed by a sustained increase in lymphocytes (days 6, 14 and 21). Hydroxyproline levels increased in bleomycin‐treated mice on days 14 and 21. Median SMI grades were significantly elevated on days 3, 14 and 21. Computer‐assisted morphometry demonstrated a 3‐fold increase in fibrosis fraction and a 1.3‐fold increase in wall area fraction in bleomycin‐treated mice on day 14, with no further increase on day 21. These data also demonstrate that the most suitable time point for assessing lung fibrosis in this model is 14 days after IT instillation of bleomycin, based on the observation that at 14 days the animals developed extensive fibrosis, but had less variability in the fibrotic response and lower mortality than later at 21 days. Computer‐assisted morphometry provides objective and quantitative measurements that are a useful tool for the evaluation of bleomycin‐induced lung injury.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2613.2002.00220.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bleomycin-induced lung injury in mice recapitulates critical features of human IPF.

    “Aerosolized intratracheal instillation of the chemotherapeutic agent bleomycin induces lung fibrosis in mice and recapitulates critical features of human IPF15.”

    From Cellular senescence mediates fibrotic pulmonary disease (2017) · cites this paper as [15]

Cited by

Sorted by citations

Authors
Izbicki, G., Segel, M. J., Christensen, T. G., Conner, M. W., & Breuer, R.
Affiliations
  • Hebrew University of Jerusalem (IL)
  • Boston University (US)
Corresponding author
Breuer, R.
Venue
International Journal of Experimental Pathology
Publisher
Wiley
Published
2002-06
Volume
83
Issue
3
Pages
111-119
ISSN
  • 0959-9673 (ISSN-L)
  • 1365-2613
OpenAlex
W1879089985
Cited by
447
References
0
Citations by year
2026: 20 · 2025: 31 · 2024: 34 · 2023: 37 · 2022: 29 · 2021: 30 · 2020: 29 · 2019: 19 · 2018: 15 · 2017: 26 · 2016: 20 · 2015: 18 · 2014: 17 · 2013: 15 · 2012: 12
FWCI
4.94
Type
journal article
Language
en
Open access
Locations
  • International Journal of Experimental Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • School of Medicine, Boston University
  • Hebrew University of Jerusalem
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Keywords
bleomycin, pulmonary fibrosis, bleomycin-induced lung injury, intratracheal instillation, computer-assisted morphometry, bronchoalveolar lavage, hydroxyproline, neutrophils, lymphocytes, mouse model
MeSH terms
Animals, Antimetabolites, Antineoplastic, Bleomycin, Bronchoalveolar Lavage Fluid, Cell Count, Hydroxyproline, Image Processing, Computer-Assisted, Instillation, Drug, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Time Factors, Models, Animal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review